scispace - formally typeset
T

Takeo Yoshikawa

Researcher at RIKEN Brain Science Institute

Publications -  294
Citations -  13261

Takeo Yoshikawa is an academic researcher from RIKEN Brain Science Institute. The author has contributed to research in topics: Single-nucleotide polymorphism & Bipolar disorder. The author has an hindex of 57, co-authored 263 publications receiving 12000 citations. Previous affiliations of Takeo Yoshikawa include Tokyo Medical and Dental University & Tokyo Metropolitan Matsuzawa Hospital.

Papers
More filters
Journal ArticleDOI

Variable number of tandem repeat polymorphisms of DRD4: re-evaluation of selection hypothesis and analysis of association with schizophrenia

TL;DR: This study suggests that the VNTR variation does not have an effect large enough to cause either selection or a detectable association with schizophrenia in a study of samples of moderate size.
Journal ArticleDOI

Role of METTL20 in regulating β-oxidation and heat production in mice under fasting or ketogenic conditions.

TL;DR: It is shown that Mettl20 knockout mice fed a ketogenic diet had higher oxygen consumption and heat production and a subsequent cold tolerance test conducted after 24 h of fasting indicated that the KO mice had a better ability to maintain their body temperature in cold environments.
Journal ArticleDOI

Evidence for Altered Metabolism of Sphingosine-1-Phosphate in the Corpus Callosum of Patients with Schizophrenia

TL;DR: It is suggested that an altered S1P metabolism may underlie the deficits in oligodendrocyte differentiation and myelin formation, leading to the structural and molecular abnormalities of white matter reported in schizophrenia.
Journal ArticleDOI

Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia.

TL;DR: In this paper, a quantitative trait loci analysis using C57BL/6 (B6) mice with better PPI performance and C3H/He (C3) with lower PPI score was performed to determine which gene is likely to explain the PPI difference and whether the gene is potentially relevant to schizophrenia.